CSL (ASX:CSL) launches $17 billion offer for Swedish-based Vifor Pharma
Lachlan Buur-Jensen
December 14, 2021
CSL Limited (ASX: CSL) has announced a blockbuster US$12.3 billion
CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.
CSL Limited (ASX: CSL) has announced a blockbuster US$12.3 billion
The S&P/ASX 200 (ASX: XJO) managed another strong opening on
Is the Washington H. Soul Pattinson and Co. Ltd (ASX:SOL)
The S&P/ASX 200 (INDEXASX:XJO) managed to eke out a tiny
It was a negative week for stock markets as the
The S&P/ASX 200 (ASX: XJO) bucked the trend to gain
The CSL Limited (ASX:CSL) share price is in focus on
Washington H. Soul Pattinson (ASX: SOL) is almost a dividend
There are quite a few ASX shares that I prefer
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
Here you go: A $50,000 per year passive income special report
Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.
Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.
Unsubscribe anytime. Read our Terms, Financial Services Guide, Privacy Policy. We’ll never sell your email address. Our company is Australian owned.